Skip to content

Clinical trials

Phase 4 Insulin Resistance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 4 Clear all

284 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20024
200312
200416
200519
200615
200717
200815
200915
201010
201122
201217
201314
201413
201514
201612
20178
201813
20198
20202
20215
20224
20237
20243
20259
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed204
Unknown status37
Terminated23
Recruiting7
Withdrawn7
Not yet recruiting4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gachon University Gil Medical Center11
Eli Lilly and Company4
Massachusetts General Hospital4
Stanford University4
Tanabe Pharma Corporation4
Tottori University Hospital4
University Medical Centre Ljubljana4
AstraZeneca3
German Diabetes Center3
Mannkind Corporation3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance284
Diabetes Mellitus, Type 276
Diabetes Mellitus66
Obesity28
Metabolic Syndrome25
Glucose Intolerance16
Inflammation16
Hyperglycemia15
Diabetes Mellitus, Type 114
Hypertension14

Trials

Showing 26 to 50 of 284. Each trial links to its page on Pharma Observatory.

184 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.